Lab Report Summary & Interpretation

HAEMATOLOGY

BIOCHEMISTRY - RENAL PROFILE

BIOCHEMISTRY - LIPID PROFILE

• Regular aerobic exercise (brisk walking, jogging, cycling - at least 30 min/day)
• Reducing refined carbohydrates and trans fats
• Avoiding smoking
• Including healthy fats (nuts, olive oil, avocado, fatty fish)

BLOOD SUGAR

URINE ROUTINE

Summary & Actionable Points

This interpretation is for informational purposes. Please discuss the results with your treating physician (Dr. Dhanya Louis J S) for personalised medical advice.

Can a Perfect HbA1c Mask Underlying Insulin Resistance?

• Height: 180 cm, Weight: 94 kg
• BMI = 94 / (1.80)² = 29.0 kg/m² - Overweight (just below the obesity threshold of 30)
• For South/Southeast Asian populations, the WHO-recommended cutoff for obesity risk is BMI ≥ 23 kg/m², which means he is already in the obese risk category by Asian standards.

The Physiology: Why Blood Sugar Can Look Perfect Despite Insulin Resistance

"In the early stages of the disorder, glucose tolerance remains near-normal, despite insulin resistance, because the pancreatic beta cells compensate by increasing insulin output... The onset of insulin resistance is heralded by postprandial hyperinsulinemia, which is followed by fasting hyperinsulinemia and ultimately by hyperglycemia."

Step 1: Insulin resistance develops (muscle/liver/fat don't respond normally)
         ↓
Step 2: Pancreas secretes MORE insulin to overcome resistance
         ↓
Step 3: Blood glucose stays normal → HbA1c looks "perfect"
         ↓
Step 4: Eventually beta cells exhaust → glucose starts rising → Prediabetes → T2DM

"Insulin resistance is the predominant defect in more than 90% of patients with T2D, often preceding a diagnosis of T2D by 10 to 15 years."

His Specific Risk Profile

How to Test for Insulin Resistance

HOMA-IR = [Fasting Serum Insulin (µU/mL) × Fasting Glucose (mg/dL)] / 405

• HOMA-IR < 1.0 = insulin sensitive
• HOMA-IR 1.0 - 1.9 = early insulin resistance
• HOMA-IR ≥ 2.0 = significant insulin resistance
• (From Fuster & Hurst's The Heart, 15th Ed.: "HOMA-IR predictive of CVD, with a one-unit increase associated with a 5.4% increased risk")

Can He Prevent Diabetes if Insulin Resistance is Confirmed?

• Lifestyle modification (caloric restriction + exercise) reduced progression to T2DM by 58% over 4 years
• Metformin reduced progression by 31%
• Every 1 kg of weight loss = 16% reduction in T2DM risk
• Maximal benefit seen at 7-10% body weight loss (for him: losing ~6.5-9.5 kg, i.e., getting to 84-87 kg)
• The benefit persisted at 10-year follow-up

Practical Recommendations for His Case

Tests to Order Now

1. Fasting Serum Insulin - single most useful test
2. Calculate HOMA-IR once insulin result is available
3. Optional: OGTT with insulin curve (if insulin is borderline)

If Insulin Resistance is Confirmed: Target These

Even if Insulin Resistance is Normal

Bottom Line

This is for informational purposes. His treating physician should order and interpret the insulin studies in clinical context.

HOMA-IR Calculation & Interpretation

The Calculation

HOMA-IR = [Fasting Insulin (µU/mL) × Fasting Glucose (mg/dL)] ÷ 405

HOMA-IR = [21.44 × 86] ÷ 405 = 1843.84 ÷ 405 = 4.55

What Does 4.55 Mean?

"In the early stages of the disorder, glucose tolerance remains near-normal, despite insulin resistance, because the pancreatic beta cells compensate by increasing insulin output."

"Insulin resistance stimulates compensatory hyperinsulinemia in an attempt to maintain normal glucose concentrations. Over time, hyperglycemia occurs as the consequence of the inability of β cells to produce enough insulin; subsequent pancreatic exhaustion results in insulinopenia."

What This Means for His Overall Profile

"Insulin resistance often preceding a diagnosis of T2D by 10 to 15 years... insulin resistance is an independent risk factor when adjusted for lipid profile, HTN, and family history."

The Risk if Untreated

NOW: HOMA-IR 4.55, normal glucose (compensated phase)
         ↓  (months to years of beta cell stress)
Postprandial hyperglycemia begins → Prediabetes (IFG/IGT)
         ↓
Fasting hyperglycemia rises
         ↓
HbA1c crosses 5.7% → Pre-diabetes officially diagnosed
         ↓
HbA1c > 6.5% → Type 2 Diabetes
         ↓
Cardiovascular complications (10-15 year risk accelerated)

What to Do: Evidence-Based Action Plan

"Type 2 DM is preceded by a period of IGT or IFG, and a number of lifestyle modifications and pharmacologic agents prevent or delay the onset of DM... intensive changes in lifestyle (diet and exercise for 30 min/day five times/week) prevented or delayed T2DM by 58%... the effects of the intervention persisted for at least 15 years."

1. Weight Loss - The Most Powerful Intervention

• Target: lose 6-9 kg (reducing to ~85-88 kg) - this is the 7-10% threshold where diabetes risk drops by ~80% (Diabetes Prevention Program data)
• Even 5% weight loss measurably improves HOMA-IR
• Each kilogram lost = 16% reduction in T2DM risk

2. Exercise

• 150 min/week of moderate aerobic activity (brisk walk, cycling, swimming) - this directly increases GLUT-4 expression in skeletal muscle, improving insulin sensitivity independent of weight loss
• Resistance/strength training - muscle mass is the primary glucose disposal site; building muscle lowers HOMA-IR significantly
• Both types together are more effective than either alone

3. Diet

• Reduce refined carbohydrates, white rice, maida, sugar-sweetened drinks - these cause rapid insulin spikes and worsen resistance
• Increase dietary fiber (vegetables, legumes, whole grains) - slows glucose absorption, reduces insulin demand
• Healthy fats (nuts, olive oil, fish) over trans/saturated fats
• Intermittent fasting or time-restricted eating - reduces fasting insulin significantly in insulin-resistant individuals

4. Sleep

• Chronic sleep deprivation independently worsens insulin sensitivity (RCT evidence, PMID 37955852 - Zuraikat et al., Diabetes Care 2024)
• Target 7-8 hours of quality sleep

5. Pharmacological Consideration (Physician Decision)

• Metformin - reduces T2DM onset by 31%, improves insulin sensitivity, low cost, proven safety; especially appropriate when HOMA-IR is elevated with overweight
• GLP-1 receptor agonists (e.g., semaglutide) - newer agents with greater weight loss and insulin-sensitizing effects; now being used in pre-diabetic insulin resistance
• These are physician-guided decisions, not self-initiated

Follow-Up Monitoring

Summary in Plain Terms

Please have him discuss these results with his treating physician (Dr. Dhanya Louis J S) for a formal management plan. Metformin or other pharmacological support may be appropriate alongside lifestyle changes given the HOMA-IR of 4.55.

HOMA-IR Recalculated (Confirmed Values)

Key Points to Note

• The fasting insulin of 21.44 µU/mL alone is already diagnostic of hyperinsulinemia. Normal fasting insulin in a healthy, non-insulin-resistant individual is typically < 8-10 µU/mL. His value is more than twice the upper limit of normal.
• The FBS of 86 mg/dL is being held in the normal range only because the pancreas is producing that excess insulin. If his beta cells were secreting a normal amount of insulin (say 5-8 µU/mL) without the resistance, his blood glucose would likely be significantly higher.
• HOMA-IR of 4.55 with a weight of 94 kg and BMI of 29 (obese by Asian standards) is a clinically significant finding that warrants formal management - not just monitoring.

Differential Diagnosis: Elevated Fasting Insulin (21.44 µU/mL) with Normal Glucose (86 mg/dL)

Tier 1 - Most Likely (Fits his profile perfectly)

1. Insulin Resistance / Metabolic Syndrome (already confirmed by HOMA-IR 4.55)

• The pancreas secretes excess insulin to overcome tissue resistance
• Glucose is kept normal at the cost of chronic hyperinsulinemia
• Driven by obesity (BMI 29, Asian obese), visceral fat, and free fatty acids
• His low HDL (39), overweight status, and clinical picture are textbook features
• Yamada's Gastroenterology specifically notes: "false-positive values will be found in obese patients because insulin resistance requires an elevated fasting insulin to maintain a normal fasting glucose level"

2. Non-Alcoholic Fatty Liver Disease (NAFLD)

• NAFLD and insulin resistance are so tightly linked they are considered two faces of the same condition
• Goldman-Cecil Medicine: "Two fundamental but related defects in NAFLD are insulin resistance/hyperinsulinemia and excessive levels of circulating nonesterified fatty acids"
• Tietz Textbook of Lab Medicine: elevated fasting insulin is a feature of NAFLD alongside raised BMI, triglycerides, and low HDL - all features present in this patient
• He should be screened with a liver ultrasound and LFTs (ALT/AST) if not already done
• He may have fatty liver silently, which is itself driving the insulin resistance further

Tier 2 - Secondary Endocrine Causes (Must Rule Out)

3. Cushing Syndrome (Cortisol Excess)

• Excess cortisol causes visceral obesity, promotes gluconeogenesis, and directly induces insulin resistance and compensatory hyperinsulinemia
• Classic features: central obesity, moon face, buffalo hump, striae, hypertension
• Subclinical Cushing can present with just obesity and metabolic derangement
• Screening test: 24-hour urinary free cortisol or overnight 1 mg dexamethasone suppression test

4. Hypothyroidism

• Thyroid hormone deficiency reduces glucose uptake in peripheral tissues, reduces GLUT-4 expression, and causes insulin resistance
• Sleisenger & Fordtran: hypothyroidism listed alongside Cushing syndrome and acromegaly as endocrine disorders causing obesity, insulin resistance, and hyperinsulinemia
• Can be subclinical - mild TSH elevation without overt symptoms
• Simple TSH test rules this in or out
• Especially important: hypothyroidism can also explain the low HDL, weight gain, and fatigue

5. Acromegaly (Growth Hormone Excess)

• GH directly antagonises insulin action at receptor and post-receptor levels, causing marked insulin resistance and compensatory hyperinsulinemia
• Andrews' Dermatology notes acromegaly causes hyperinsulinemia significant enough to produce acanthosis nigricans
• Features: coarsening of facial features, enlarged hands/feet, jaw changes, headache, visual field defects
• Screening: IGF-1 level
• Less likely at 31 years with no features, but worth noting in the differential

6. Polycystic Ovary Syndrome (PCOS) equivalent - Male Hyperandrogenism

• In women, PCOS is the classic cause of hyperinsulinemia with normal glucose
• In men, a similar state can exist with insulin resistance linked to androgen dysregulation
• Berek & Novak's Gynecology: "Patients with PCOS frequently exhibit IR and hyperinsulinemia... insulin alters ovarian steroidogenesis independent of gonadotropin secretion"
• Clinically relevant: testosterone and SHBG levels should be checked in an insulin-resistant male; low SHBG is a marker of insulin resistance in men

Tier 3 - Less Likely but Clinically Important to Exclude

7. Insulinoma (Pancreatic Beta-Cell Tumour)

• Classically causes fasting hypoglycemia + high insulin + high C-peptide
• Against this diagnosis in his case: FBS is 86 mg/dL (not hypoglycaemic)
• Yamada's Gastroenterology: insulin/glucose ratio >0.3 is consistent with insulinoma syndrome, but this is a false positive in obese, insulin-resistant patients
• Bailey & Love's Surgery: diagnosis requires Whipple's triad - symptoms of hypoglycaemia, documented low glucose (<50 mg/dL or <3.0 mmol/L) during symptoms, and relief with glucose
• He does NOT meet Whipple's triad - insulinoma is effectively ruled out by his normal fasting glucose
• However, if he ever reports fasting dizziness, sweating, or confusion, re-evaluate

8. Exogenous Insulin / Factitious Hyperinsulinism

• Someone injecting exogenous insulin would have HIGH insulin but LOW C-peptide (because exogenous insulin suppresses endogenous C-peptide)
• Rosen's Emergency Medicine: "A patient surreptitiously administering exogenous insulin will have normal to low levels of C-peptide and markedly elevated insulin levels"
• To distinguish: measure C-peptide simultaneously
  • High insulin + High C-peptide = endogenous (body is making it itself - insulin resistance, insulinoma)
  • High insulin + Low C-peptide = exogenous insulin administration
• Not clinically relevant here unless deliberately explored

9. Certain Medications

• Drugs that elevate insulin or cause insulin resistance:
  • Corticosteroids (e.g., prednisolone) - major cause
  • Antipsychotics (olanzapine, clozapine) - cause insulin resistance and hyperinsulinemia
  • Beta-blockers - impair insulin secretion and glucose metabolism
  • Thiazide diuretics - hypokalemia-mediated insulin resistance
  • Protease inhibitors (HIV medications) - lipodystrophy + insulin resistance
• Ask about any current medications

10. Sleep Apnoea (Obstructive Sleep Apnoea - OSA)

• OSA independently causes insulin resistance via intermittent hypoxia, sympathetic activation, and cortisol dysregulation
• Very common in overweight males (BMI 29, male gender, age 31)
• RCT evidence (PMID 37955852, Diabetes Care 2024): insufficient sleep impairs insulin sensitivity independent of weight
• Goldman-Cecil Medicine lists sleep apnoea as a comorbidity of NAFLD and metabolic syndrome

Summary Table

What to Investigate Next for This Patient

1. C-peptide - to confirm endogenous hyperinsulinemia (expected to be high, consistent with insulin resistance, NOT exogenous injection)
2. TSH + Free T4 - to rule out hypothyroidism driving or worsening the resistance
3. Liver ultrasound + ALT/AST - to look for NAFLD, which is almost certainly co-existing
4. Testosterone + SHBG - low SHBG is a sensitive marker of insulin resistance in males
5. Blood pressure check - hyperinsulinemia causes sodium retention and sympathetic activation, raising hypertension risk
6. Waist circumference - if >90 cm in an Asian male, confirms abdominal obesity and metabolic syndrome formally

Normal LFTs Do NOT Exclude NAFLD

"NAFLD is the most common cause of elevated transaminases, although a significant proportion - 30 to 60% of patients - may have normal liver enzymes."

"The degree of necroinflammatory damage is not related to increases in AST or ALT activity, and the likelihood of significant liver damage is similar in those with normal [ALT]..."

So Where Does This Leave the Differential?

The Only Way to Exclude NAFLD is Imaging

• BMI 29 (obese by Asian standards)
• HOMA-IR 4.55 (significant insulin resistance)
• Low HDL
• Yamada's note that "prevalence of NAFLD correlates with BMI, and in cohorts undergoing bariatric surgery, up to 90% may demonstrate NAFLD"